WITHDRAWN: Common NLRP3 inflammasome inhibitors and Covid-19: Divide and Conquer
Gaber El‐Saber Batiha, Ali I. Al‐Gareeb, Safaa Qusti, Eida M. Alshammari, Damilare Rotimi, Oluyomi Stephen Adeyemı, Hayder M. Al‐kuraishy
Abstract
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)InflammasomeDivide and conquer algorithmsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineComputer sciencePolitical scienceVirologyInternal medicineInflammationAlgorithmDiseaseOutbreakInfectious disease (medical specialty)Inflammasome and immune disordersCOVID-19 Clinical Research StudiesCalcium signaling and nucleotide metabolism